Smith+Nephew, Watford, United Kingdom, announced an exclusive US distribution agreement with RMR Ortho to add the A’TOMIC Nitinol Fixation System to its Trauma, Foot & Ankle, and Hand & Wrist portfolio.
The A’TOMIC system leverages proprietary manufacturing methods and the unique properties of nitinol to provide compressive fixation implants featuring a wide bridge with barbed, round legs that match drill holes. The system is engineered to achieve stability of fusion, fracture, and osteotomy sites through high strength and active compression, designed to improve implant integrity and patient comfort.
“This partnership strengthens Smith+Nephew’s fixation portfolio by adding a dynamic compression fixation solution that complements our existing technologies,” said Scott Gunn, Vice President of U.S. Marketing, Trauma, Extremities, and Shoulder at Smith+Nephew. The agreement expands the company’s ability to participate in high-frequency fracture and arthrodesis procedures while leveraging established Extremities and Trauma sales channels.
“Partnering with Smith+Nephew represents an important step forward as we continue to expand access to the A’TOMIC Nitinol Fixation System across key U.S. territories,” said Joe Ritz, CEO of RMR Ortho.
Smith+Nephew is a global medical technology company operating in more than 100 countries with approximately 18,000 employees.
[www.smith-nephew.com](https://www.smith-nephew.com)
